Literature DB >> 21373966

L1 stimulation of human glioma cell motility correlates with FAK activation.

Muhua Yang1, Yupei Li, Kalyani Chilukuri, Owen A Brady, Magdy I Boulos, John C Kappes, Deni S Galileo.   

Abstract

The neural adhesion/recognition protein L1 (L1CAM; CD171) has been shown or implicated to function in stimulation of cell motility in several cancer types, including high-grade gliomas. Our previous work demonstrated the expression and function of L1 protein in stimulation of cell motility in rat glioma cells. However, the mechanism of this stimulation is still unclear. This study further investigated the function of L1 and L1 proteolysis in human glioblastoma multiforme (GBM) cell migration and invasion, as well as the mechanism of this stimulation. L1 mRNA was found to be present in human T98G GBM cell line but not in U-118 MG grade III human glioma cell line. L1 protein expression, proteolysis, and release were found in T98G cells and human surgical GBM cells by Western blotting. Exosome-like vesicles released by T98G cells were purified and contained full-length L1. In a scratch assay, T98G cells that migrated into the denuded scratch area exhibited upregulation of ADAM10 protease expression coincident with loss of surface L1. GBM surgical specimen cells exhibited a similar loss of cell surface L1 when xenografted into the chick embryo brain. When lentivirally introduced shRNA was used to attenuate L1 expression, such T98G/shL1 cells exhibited significantly decreased cell motility by time lapse microscopy in our quantitative Super Scratch assay. These cells also showed a decrease in FAK activity and exhibited increased focal complexes. L1 binding integrins which activate FAK were found in T98G and U-118 MG cells. Addition of L1 ectodomain-containing media (1) rescued the decreased cell motility of T98G/shL1 cells and (2) increased cell motility of U-118 MG cells but (3) did not further increase T98G cell motility. Injection of L1-attenuated T98G/shL1 cells into embryonic chick brains resulted in the absence of detectable invasion compared to control cells which invaded brain tissue. These studies support a mechanism where glioma cells at the edge of a cell mass upregulate ADAM10 to proteolyze surface L1 and the resultant ectodomain increases human glioma cell migration and invasion by binding to integrin receptors, activating FAK, and increasing turnover of focal complexes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21373966      PMCID: PMC3172337          DOI: 10.1007/s11060-011-0557-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  56 in total

1.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

2.  ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles.

Authors:  Paul Gutwein; Sabine Mechtersheimer; Svenja Riedle; Alexander Stoeck; Daniela Gast; Safwan Joumaa; Hanswalter Zentgraf; Mina Fogel; D Peter Altevogt
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

3.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  The adhesion molecule L1 (CD171) promotes melanoma progression.

Authors:  Friedegund Meier; Silke Busch; Daniela Gast; Anne Göppert; Peter Altevogt; Evelyn Maczey; Svenja Riedle; Claus Garbe; Birgit Schittek
Journal:  Int J Cancer       Date:  2006-08-01       Impact factor: 7.396

5.  L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin.

Authors:  O Ebeling; A Duczmal; S Aigner; C Geiger; S Schöllhammer; J T Kemshead; P Möller; R Schwartz-Albiez; P Altevogt
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

6.  Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice.

Authors:  W Chen; X Wu; D N Levasseur; H Liu; L Lai; J C Kappes; T M Townes
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

7.  Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma.

Authors:  Anka Thies; Melitta Schachner; Ingrid Moll; Jürgen Berger; Hans-Joachim Schulze; Georg Brunner; Udo Schumacher
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

8.  Effects of irradiation on the expression of the adhesion molecules (NCAM, ICAM-1) by glioma cell lines.

Authors:  R Yamanaka; R Tanaka; S Yoshida
Journal:  Neurol Med Chir (Tokyo)       Date:  1993-11       Impact factor: 1.742

9.  Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

Authors:  Nancy Gavert; Michal Sheffer; Shani Raveh; Simone Spaderna; Michael Shtutman; Thomas Brabletz; Francis Barany; Phillip Paty; Daniel Notterman; Eytan Domany; Avri Ben-Ze'ev
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

10.  Biosynthesis and membrane topography of the neural cell adhesion molecule L1.

Authors:  A Faissner; D B Teplow; D Kübler; G Keilhauer; V Kinzel; M Schachner
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  28 in total

1.  Host matrix modulation by tumor exosomes promotes motility and invasiveness.

Authors:  Wei Mu; Sanyukta Rana; Margot Zöller
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

Review 2.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27

3.  L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.

Authors:  Vishnu Mohanan; Murali K Temburni; John C Kappes; Deni S Galileo
Journal:  Clin Exp Metastasis       Date:  2012-12-01       Impact factor: 5.150

Review 4.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

5.  Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.

Authors:  Hannah J Anderson; Deni S Galileo
Journal:  Cell Oncol (Dordr)       Date:  2016-02-16       Impact factor: 6.730

6.  MDA-9/syntenin is a key regulator of glioma pathogenesis.

Authors:  Timothy P Kegelman; Swadesh K Das; Bin Hu; Manny D Bacolod; Christine E Fuller; Mitchell E Menezes; Luni Emdad; Santanu Dasgupta; Albert S Baldwin; Jeffrey N Bruce; Paul Dent; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 7.  The malignant social network: cell-cell adhesion and communication in cancer stem cells.

Authors:  James S Hale; Meizhang Li; Justin D Lathia
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

8.  L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.

Authors:  Jin-Cheng Guo; Yang-Min Xie; Li-Qiang Ran; Hui-Hui Cao; Chun Sun; Jian-Yi Wu; Zhi-Yong Wu; Lian-Di Liao; Wei-Jiang Zhao; Wang-Kai Fang; En-Min Li; Li-Yan Xu; Melitta Schachner; Jian-Jun Xie
Journal:  J Mol Med (Berl)       Date:  2017-09-22       Impact factor: 4.599

9.  L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.

Authors:  Xiaodong Guo; Lu Xiong; Lin Zou; Ting Sun; Jing Zhang; Hanwei Li; Ruiyun Peng; Jingmin Zhao
Journal:  Diagn Pathol       Date:  2012-08-13       Impact factor: 2.644

10.  Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles.

Authors:  Laura M Epple; Steve G Griffiths; Anjelika M Dechkovskaia; Nathaniel L Dusto; Jason White; Rodney J Ouellette; Thomas J Anchordoquy; Lynne T Bemis; Michael W Graner
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.